This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Comment

. 1994 Oct 13;331(15):1022-3.

doi: 10.1056/NEJM199410133311515.

Mortality in sickle cell disease

G P Rodgers, E C Walker, M J Podgor

PMID: 8084346
DOI: 10.1056/NEJM199410133311515

Comment

Mortality in sickle cell disease

G P Rodgers et al. N Engl J Med. 1994.

. 1994 Oct 13;331(15):1022-3.

doi: 10.1056/NEJM199410133311515.

Authors

G P Rodgers, E C Walker, M J Podgor

PMID: 8084346
DOI: 10.1056/NEJM199410133311515

No abstract available

PubMed Disclaimer

Comment on

Mortality in sickle cell disease. Life expectancy and risk factors for early death.
Platt OS, Brambilla DJ, Rosse WF, Milner PF, Castro O, Steinberg MH, Klug PP. Platt OS, et al. N Engl J Med. 1994 Jun 9;330(23):1639-44. doi: 10.1056/NEJM199406093302303. N Engl J Med. 1994. PMID: 7993409

Similar articles

Pulmonary hypertension as a risk factor for death in patients with sickle cell disease.
Hassoun PM, Krishnan JA. Hassoun PM, et al. N Engl J Med. 2004 Jun 10;350(24):2521-2; author reply 2521-2. N Engl J Med. 2004. PMID: 15195345 No abstract available.
Pulmonary hypertension in sickle cell disease.
Vichinsky EP. Vichinsky EP. N Engl J Med. 2004 Feb 26;350(9):857-9. doi: 10.1056/NEJMp038250. N Engl J Med. 2004. PMID: 14985481 No abstract available.
Pulmonary hypertension as a risk factor for death in patients with sickle cell disease.
Klings ES, Farber HW. Klings ES, et al. N Engl J Med. 2004 Jun 10;350(24):2521-2; author reply 2521-2. doi: 10.1056/NEJM200406103502418. N Engl J Med. 2004. PMID: 15190149 No abstract available.
Infection in sickle cell disease: a review.
Booth C, Inusa B, Obaro SK. Booth C, et al. Int J Infect Dis. 2010 Jan;14(1):e2-e12. doi: 10.1016/j.ijid.2009.03.010. Epub 2009 Jun 3. Int J Infect Dis. 2010. PMID: 19497774 Review.
[Treatment of major sickle cell syndromes. The point of view of the internist].
Godeau B. Godeau B. Bull Soc Pathol Exot. 2001 May;94(2):90-1. Bull Soc Pathol Exot. 2001. PMID: 11475034 Review. French.

See all similar articles

Cited by

Unexpected Death of a Sickle Cell Disease Patient: A Case Report and Literature Review.
Zhou G, Mohammad A, Shan Y. Zhou G, et al. Cureus. 2024 Jun 18;16(6):e62645. doi: 10.7759/cureus.62645. eCollection 2024 Jun. Cureus. 2024. PMID: 39036104 Free PMC article.
Simvastatin-Mediated Nrf2 Activation Induces Fetal Hemoglobin and Antioxidant Enzyme Expression to Ameliorate the Phenotype of Sickle Cell Disease.
Xi C, Palani C, Takezaki M, Shi H, Horuzsko A, Pace BS, Zhu X. Xi C, et al. Antioxidants (Basel). 2024 Mar 11;13(3):337. doi: 10.3390/antiox13030337. Antioxidants (Basel). 2024. PMID: 38539870 Free PMC article.
Transsulfuration pathway activation attenuates oxidative stress and ferroptosis in sickle primary erythroblasts and transgenic mice.
Xi C, Pang J, Xue W, Cui Y, Jiang N, Zhi W, Shi H, Horuzsko A, Pace BS, Zhu X. Xi C, et al. Commun Biol. 2025 Jan 6;8(1):15. doi: 10.1038/s42003-024-07424-7. Commun Biol. 2025. PMID: 39762627 Free PMC article.
Cross-cultural adaptation of the Pain Medication Questionnaire for use in Brazil.
Galindo SR, da Nóbrega Marinho MH, Gatchel RJ, de Paula Santana da Silva T, Viana EHS, Vasconcelos SC, da Costa Lima MD. Galindo SR, et al. BMC Med Res Methodol. 2019 Sep 23;19(1):188. doi: 10.1186/s12874-019-0821-x. BMC Med Res Methodol. 2019. PMID: 31547804 Free PMC article.

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- Atypon
- Ovid Technologies, Inc.
Medical
- MedlinePlus Health Information